AXA SA (AXA.DE) Stock Fundamental Analysis
FRA:AXA - Deutsche Boerse Ag - FR0000120628 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to AXA. AXA was compared to 33 industry peers in the Insurance industry. Both the profitability and the financial health of AXA get a neutral evaluation. Nothing too spectacular is happening here. AXA has a decent growth rate and is not valued too expensively. Finally AXA also has an excellent dividend rating. These ratings would make AXA suitable for dividend investing!
1. Profitability
1.1 Basic Checks
In the past year AXA was profitable.
AXA had a positive operating cash flow in the past year.
AXA had positive earnings in each of the past 5 years.
In the past 5 years AXA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of AXA (1.18%) is better than 60.61% of its industry peers.
The Return On Equity of AXA (15.39%) is better than 60.61% of its industry peers.
With a decent Return On Invested Capital value of 1.33%, AXA is doing good in the industry, outperforming 60.61% of the companies in the same industry.
AXA had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 2.22%.
The 3 year average ROIC (1.29%) for AXA is below the current ROIC(1.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 15.39% | ||
| ROIC | 1.33% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
1.3 Margins
AXA has a Profit Margin of 8.80%. This is comparable to the rest of the industry: AXA outperforms 42.42% of its industry peers.
AXA's Profit Margin has improved in the last couple of years.
AXA has a Operating Margin (12.32%) which is in line with its industry peers.
In the last couple of years the Operating Margin of AXA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.32% | ||
| PM (TTM) | 8.8% | ||
| GM | N/A |
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
AXA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AXA has been reduced compared to 1 year ago.
The number of shares outstanding for AXA has been reduced compared to 5 years ago.
AXA has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.35, we must say that AXA is in the distress zone and has some risk of bankruptcy.
AXA has a better Altman-Z score (0.35) than 93.94% of its industry peers.
AXA has a debt to FCF ratio of 2.19. This is a good value and a sign of high solvency as AXA would need 2.19 years to pay back of all of its debts.
AXA has a Debt to FCF ratio of 2.19. This is in the better half of the industry: AXA outperforms 69.70% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that AXA is somewhat dependend on debt financing.
The Debt to Equity ratio of AXA (0.53) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.19 | ||
| Altman-Z | 0.35 |
ROIC/WACC0.13
WACC10.54%
2.3 Liquidity
A Current Ratio of 0.87 indicates that AXA may have some problems paying its short term obligations.
The Current ratio of AXA (0.87) is better than 84.85% of its industry peers.
AXA has a Quick Ratio of 0.87. This is a bad value and indicates that AXA is not financially healthy enough and could expect problems in meeting its short term obligations.
AXA has a better Quick ratio (0.87) than 84.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.87 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
AXA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.08%, which is quite good.
AXA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.09% yearly.
AXA shows a small growth in Revenue. In the last year, the Revenue has grown by 4.38%.
The Revenue has been decreasing by -8.16% on average over the past years.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
3.2 Future
AXA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.32% yearly.
AXA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.73% yearly.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue Next Year6%
Revenue Next 2Y5.31%
Revenue Next 3Y2.48%
Revenue Next 5Y7.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
AXA is valuated reasonably with a Price/Earnings ratio of 11.79.
Based on the Price/Earnings ratio, AXA is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.22, AXA is valued rather cheaply.
A Price/Forward Earnings ratio of 10.57 indicates a reasonable valuation of AXA.
AXA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AXA is cheaper than 63.64% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AXA to the average of the S&P500 Index (20.86), we can say AXA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.79 | ||
| Fwd PE | 10.57 |
4.2 Price Multiples
AXA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AXA is cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.82 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AXA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.02
PEG (5Y)0.65
EPS Next 2Y9.13%
EPS Next 3Y8.44%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.34%, AXA is a good candidate for dividend investing.
AXA's Dividend Yield is a higher than the industry average which is at 4.56.
AXA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.34% |
5.2 History
The dividend of AXA is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
AXA pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of AXA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
FRA:AXA (5/2/2025, 7:00:00 PM)
42.32
+0.74 (+1.78%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners36.79%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap93.74B
Analysts80
Price Target43.29 (2.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.34% |
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.75%
PT rev (3m)7.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.36%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)6.31%
Revenue NY rev (3m)11.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.79 | ||
| Fwd PE | 10.57 | ||
| P/S | 1.07 | ||
| P/FCF | 7.82 | ||
| P/OCF | 7.52 | ||
| P/B | 1.88 | ||
| P/tB | 3.42 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.59
EY8.48%
EPS(NY)4.01
Fwd EY9.46%
FCF(TTM)5.41
FCFY12.79%
OCF(TTM)5.63
OCFY13.3%
SpS39.43
BVpS22.55
TBVpS12.36
PEG (NY)1.02
PEG (5Y)0.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 15.39% | ||
| ROCE | 1.67% | ||
| ROIC | 1.33% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.79% | ||
| OM | 12.32% | ||
| PM (TTM) | 8.8% | ||
| GM | N/A | ||
| FCFM | 13.73% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 1.72 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 156.03% | ||
| Current Ratio | 0.87 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.35 |
F-Score7
WACC10.54%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y6.32%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6%
Revenue Next 2Y5.31%
Revenue Next 3Y2.48%
Revenue Next 5Y7.73%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%